Completed PHASE4 INTERVENTIONAL 2-arm NCT01339858

The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia (Breier-Stanley)

Sponsor: Indiana University

Conditions Psychotic Disorder NOS Schizoaffective Disorder Schizophrenia Schizophreniform

Interventions N-Acetyl Cysteine sugar pill

Updated 10 times since 2017 Last updated: Apr 17, 2019 Started: May 31, 2011 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Psychotic Disorder NOS and Schizoaffective Disorder, this trial is completed. The trial is conducted by Indiana University and has accumulated 10 data snapshots since 2011. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jun 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Jun 2019 [monthly]

Completed PHASE4
Mar 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Feb 2017 — Mar 2018 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University
Stanley Medical Research Institute

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States